All Cardiovascular articles
-
NewsSIGN releases draft guidance on venous thromboembolism in COVID-19
The draft rapid guideline is open for consultation until 3 October
-
Independent professional body guideline
ABCD position on cardiovascular impact of glucose-lowering drugs
Key recommendations from the ABCD position statement on new glucose-lowering drugs concerning their cardiovascular impact on people with diabetes
-
News
NHS England to routinely offer novel cholesterol-lowering jab
The twice-yearly inclisiran injection, which will be available through GP surgeries across England, could save 30,000 lives over the next 10 years
-
Video
Modern management of stroke prevention in non-valvular atrial fibrillation
These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100689 | Date of preparation: August 2021 -
News
Renal decline slower with rivaroxaban than warfarin in patients with atrial fibrillation
Patients with atrial fibrillation report fewer adverse renal outcomes and a slower decline in renal function on rivaroxaban compared with warfarin
-
Information
Clinical focus: cardiovascular conditions
Each month, Guidelines puts one clinical area under the spotlight. This month, we focus on the management of cardiovascular conditions from sessions recorded at Guidelines Live
-
Upcoming Live Webinars
The impact of DOACs on stroke in patients with NVAF: practical considerations for those with comorbidities
This promotional webinar has been funded by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance and organised in partnership with Guidelines.
ELIQUIS (apixaban) prescribing and adverse event reporting information.
432-GB-2100774 | August 2021 -
News
Blood pressure checks to be rolled out in community pharmacies across England
From October, every NHS pharmacy in England will be able to offer blood pressure checks to people aged 40 and over
-
NHS guideline
NHS lipid management pathway
This Guidelines summary covers key recommendations from national guidance on lipid management for the primary and secondary prevention of cardiovascular disease
-
NICE guideline
COVID-19 rapid guideline on VITT
This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination
-
News
NICE publishes new guideline on rare blood clotting associated with COVID-19 vaccination
The new guideline aims to help healthcare professionals to identify and treat patients who develop vaccine-induced immune thrombocytopenia and thrombosis after receiving COVID-19 vaccination
-
NICE guideline
NICE atrial fibrillation guideline
A clear summary of NICE’s guideline on atrial fibrillation management
-
Hosted content
Calculating renal function in patients with atrial fibrillation
This animation has been developed and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals.
432-GB-2100230 June 2021 -
Independent professional body guideline
Self Care Forum venous disease fact sheet
A summary of recommendations for advising patients and the public on managing venous disease
-
Independent professional body guideline
CaReMeUK heart failure algorithm
A heart failure management algorithm modified from the NICE guideline, Chronic heart failure in adults: diagnosis and management
-
Independent professional body guideline
CaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
-
News
NICE publishes new atrial fibrillation guideline
NICE’s new guideline Atrial fibrillation: diagnosis and management updates and replaces NICE guideline CG180, and includes recommendations for providing the best care and treatment for adults with atrial fibrillation
-
Video
The holistic management of patients requiring anticoagulation
This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021 -
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
NICE guideline
NICE guideline on acute coronary syndromes
A brief summary of NICE’s clinical guideline on the management of acute coronary syndromes, which covers rehabilitation and aims to improve survival and quality of life.
